Objective: To describe the hitherto unrecognized occurrence of transient ionized hypocalcemia with acute adrenal insufficiency and its therapy.
INTRODUCTION
Many reports, particularly during the past decade, have established the entity of transient ionized hypocalcemia during acute severe illness in patients with previously normal calcium values. In addition to long-recognized causes of hypocalcemia such as hypomagnesemia, renal insufficiency, and acute pancreatitis, many such patients clearly manifest other underlying illnesses. In particular, gram-negative sepsis (1) and staphylococcal toxic shock syndrome (2) have been frequently identified in adults. Moreover, the syndrome has been identified in severely ill children, including those with gram-positive, gram-negative, and fungal sepsis (3). In both groups, patients with ionized hypocalcemia seem to have a higher mortality rate than similarly affected patients with normal serum calcium levels (1, 3) . The associated accompanying abnormalities in calcium homeostasis include depressed, normal, and increased serum parathyroid hormone (PTH) levels, suppressed and normal serum 25-hydroxyvitamin D [25(OH)D] levels, and suppressed, normal, and, rarely, increased serum 1,25-dihydroxyvitamin D [1,25(OH)2D] levels (1) .
To our knowledge, the syndrome of transient ionized hypocalcemia in acutely ill patients with adrenal insufficiency has not been previously described. Indeed, the classic description of disordered calcium homeostasis in adrenal insufficiency is that of hypercalcemia, first comprehensively reviewed by Walser et al. (4) in 1963. Both Muls et al. (5) and Suzuki et al. (6) presented data to support the hypothesis that enhanced bone resorption and increased renal tubular reabsorption of calcium were causative factors. Interestingly, however, Montoli et al. (7) were unable to demonstrate increased osteoclastic activity on bone biopsy in two patients with Addison's disease and hypercalcemia. Although most adrenally insufficient patients with hypercalcemia have primary adrenal failure, at least three patients with secondary adrenal failure and hypercalcemia have been described in published reports. Their pathogenesis may differ, however, in that each had transient thyrotoxicosis concurrently with hypercalcemia (8) (9) (10) .
In contrast, we present data in three patients to show that the syndrome of transient ionized hypocalcemia of acute illness (in contrast to hypercalcemia) may be associated with acute secondary adrenal insufficiency and its therapy and, in one case, combined primary and secondary adrenal insufficiency. Each of our patients demonstrated an appropriate transient responsive increase in serum PTH. On sequential determinations, all three patients had the anticipated increase in serum 1,25(OH)2D as well-one to supranormal levels and the other two to midnormal range from initially suppressed levels. With resolution of the acute illness in each patient, the total calcium, ionized calcium, and serum PTH returned to normal, even though depressed serum 25(OH)D levels persisted in one patient.
We postulate that these findings are multifactorial in origin, representing at a minimum the effects, alone or in combination, of the acute adrenal insufficiency, its precipitating cause, therapy with glucocorticoids, and volume expansion.
METHODS
25(OH)D and 1,25(OH)2D were measured by Nichols Institute (San Juan Capistrano, CA); after extraction with acetonitrile and purification by Sep-Pak C-18 and Sep-Pak silica columns, radioreceptor assays were used. Normal ranges in adults are 9 to 52 ng/mL and 15 to 60 pg/mL, respectively. Intact PTH was measured by using the DPC Immulite immunochemiluminescent system. Normal values are 12 to 72 pg/mL, with an interassay coefficient of variation of 8.3% at 47 pg/mL and 8.5% at 399 pg/mL. The correlation coefficient is 0.998 with the intact molecule PTH assay by immunoradiometric measurement (Nichols). Ionized calcium was measured on the Radiometer Copenhagen ABL 505 blood gas and electrolyte system by using the calcium ion-selective electrode and corrected to pH 7.40. Blood specimens were obtained anaerobically. All other analytes were determined by standard clinical chemistry procedures.
CASE REPORTS

Case 1
A 45-year-old white woman with surgical panhypopituitarism, as previously described (11) , was admitted to the hospital on Feb. 20, 1995, for the eighth time in 14 years with acute secondary adrenal insufficiency. Several previous episodes of acute adrenal insufficiency had been associated with transient decreases in serum total calcium. During such an episode in October 1990, serum cortisol and corticotropin by immunoradiometric assay were <1.0 µg/dL and <5 pg/mL, respectively. While she was receiving long-term hydrocortisone replacement of 20 mg every morning and 10 mg every evening, multiple episodes of emesis as well as several diarrheal bowel movements and epigastric and retrosternal chest discomfort developed during the 24 hours preceding admission. On examination between 0700 hours and 1200 hours, serial temperatures were 38.1, 38.2, and 38.5°C, the pulse was 85 beats/min, and blood pressure was 123/91 mm Hg without orthostatic changes. Skin turgor was poor. Other than epigastric discomfort on abdominal palpation, the findings on physical examination were unrevealing. Urinalysis and culture were negative, and results of electrolytes, hemoglobin, leukocyte count, blood urea nitrogen, creatinine, serum amylase, and liver function tests were normal. Stool and blood cultures, chest roentgenogram, cholecystogram, and ultrasound study of the liver, gallbladder, and biliary tree were negative. Therapy with intravenously administered hydrocortisone and physiologic saline was begun in the emergency department at 0800 hours, 8 hours before the first serum calcium value was determined, and continued after admission; slow improvement ensued. No calcium, vitamin D, or magnesium was administered. Laboratory data related to the incidentally noted hypocalcemia are presented in Table 1 .
Case 2
A previously described (12) 33-year-old white woman with histologically proven lymphocytic hypophysitis and isolated corticotropin deficiency felt well until the morning of Dec. 12, 1994. Her corticotropin deficiency was characterized by serum cortisol values consistently less than 1 µg/dL and plasma corticotropin <3 pg/mL in response to insulin-induced hypoglycemia at the time of initial assessment in 1991 and again on retesting in 1993. Treatment consisted of hydrocortisone, 20 mg every morning and 10 mg every evening. She awoke with cramping abdominal pain and multiple episodes of vomiting and diarrhea, together with chills and generalized body aches. Her husband and both of her children had had similar illnesses during the previous several days. On examination at 1015 hours, the patient appeared severely ill with a pulse of 130 beats/min and blood pressure of 86/70 mm Hg in the sitting position. The rest of the physical examination was unrevealing. Hydrocortisone (75 mg) was administered intravenously. Two hours later, the first measurement of serum total calcium was 7.3 mg/dL. Urinalysis, electrolytes, liver function tests, and complete blood cell count showed normal findings except for a slight decrease in the platelet count to 129 × 10 9 /L. Two blood cultures were negative.
With continued intravenous administration of hydrocortisone and isotonic saline, the patient responded with rapid improvement and was dismissed on the third hospital day. No calcium, vitamin D, or magnesium was administered. A summary of laboratory data related to the incidentally noted hypocalcemia is outlined in Table 2 .
Case 3
A 44-year-old white woman with a history of hypophysectomy and bilateral adrenalectomy for pituitary Cushing's syndrome due to a locally invasive macroadenoma sought medical assistance because of a 24-hour history of fever (temperatures as high as 40°C), dry cough, chills, weakness, nausea, dry heaves, and semiformed stools. She had been receiving long-term hydrocortisone replacement therapy (20 mg every morning and 10 mg every evening) and fludrocortisone (0.3 mg/day). On physical examination, she was unable to stand. The recumbent blood pressure was 68/50 mm Hg, pulse was 106 beats/min, and rectal temperature was 40.3°C. Diffuse hyperpigmentation and bilateral adrenalectomy scars were present. A chest roentgenogram revealed right upper lobe pneumonia, and the leukocyte count was 31.4 × 10 9 /L. Blood, urine, and stool cultures were negative, but the serum sodium concentration was 129 mEq/L and potassium level was 6.0 mEq/L. The patient was treated with intravenously administered saline and glucocorticoids, erythromycin, and ceftriaxone and a single dose (2 g) of magnesium sulfate at 1340 hours on the day of admission. No calcium or vitamin D was administered. Steady improvement was noted. Laboratory data related to the incidentally noted hypocalcemia are summarized in Table 3 .
RESULTS
Each of these patients was known have normal serum calcium levels before the episodes of acute adrenal insufficiency that resulted in hospitalization. In each of these patients, total, corrected, and ionized serum calcium decreased (in the first two patients in the absence of hypomagnesemia) and subsequently returned to normal after resolution of their acute adrenal insufficiency. One patient (case 3) demonstrated hypomagnesemia, which responded to administration of a remarkably small amount of magnesium; hence, a question arises about the possibility of transcellular shifts rather than genuine depletion. In each patient, an appropriate self-limited state of secondary hyperparathyroidism developed in response to the hypocalcemia (in case 3, questionably abetted by magnesium therapy). One patient (case 2) demonstrated a transient increase in 1,25(OH)2D to supranormal levels, whereas the other two (cases 1 and 3) showed increases in this analyte from initially suppressed levels. With longitudinal assessment, we clearly noted that one of our patients (case 1) was likely deficient in vitamin D despite return to normal PTH as well as total and ionized calcium levels. Resolution of the hypocalcemia and secondary hyperparathyroidism was achieved solely with volume replacement and glucocorticoids in two patients (cases 1 and 2). In the third patient (case 3), treatment of the pneumonia required antibiotics in addition to intravenous administration of saline, glucocorticoids, and a 2-g intramuscular dose of magnesium sulfate.
DISCUSSION
Our three patients expand the syndrome of hypocalcemia of acute illness and transient secondary hyperparathyroidism to include its association with acute adrenal insufficiency and related therapy. As is the case with hypocalcemia of acute illness involving sepsis and other conditions in patients with presumably normal adrenal function, hypocalcemia associated with adrenal crisis and therapy may be a multifactorial disorder. Although the association of adrenal insufficiency (both primary and secondary) with hypercalcemia has long been recognized (4), the occurrence of hypocalcemia in this setting apparently has not been recognized previously. Disorders previously noted to accompany hypocalcemia of acute illness, such as staphylococcal toxic shock syndrome, hyperphosphatemia, pancreatitis, and gram-negative sepsis, were notably absent in our patients; thus, the adrenal insufficiency, its precipitating cause, or its therapy may have had a causative role. This argument gains credence from two facts. First, in two of our three patients, therapy with intravenously administered saline and glucocorticoids alone was sufficient to reverse the hypocalcemia and secondary hyperparathyroidism. Second, one patient (case 1) had seven previous hospitalizations during a 14-year period for episodes of acute adrenal insufficiency. She demonstrated total hypocalcemia during each of these episodes, only one of which had an identifiable cause-salmonellosis. Although total serum calcium returned to normal after each episode (data not shown), she may have had chronic mild 25(OH)D deficiency that predisposed her to transient hypocalcemia in the setting of acute adrenal insufficiency. Of note, the initial serum calcium determinations in patients 1, 2, and 3 were obtained at 8, 2, and h ours, respectively, after intravenous administration of hydrocortisone and after institution of intravenous saline therapy. Because two patients (cases 2 and 3) had received negligible amounts of saline intravenously at this point, volume expansion is unlikely to have had a major role in the initially low total serum calcium levels obtained. Therefore, we believe that our patients' initial hypocalcemia (although ionized calcium values at this point had not been obtained in cases 2 and 3) was likely reflective of either the adrenal insufficiency or its precipitating cause. The subsequent ionized hypocalcemia, hypophosphatemia, and secondary hyperparathyroidism, however, may have been abetted by glucocorticoid administration or volume expansion (or both). In reference to the glucocorticoid effect on serum PTH and calcium, using a slight modification of the Arnaud radioimmunoassay for PTH (13), Fucik et al. (14) showed that administration of 200 mg of hydrocortisone intravenously resulted in a 72% increment over baseline in serum PTH levels at 3 hours. Importantly, however, no decrease in total serum calcium was noted. Additionally, as those authors pointed out, "this antiserum has not been characterized by reaction with defined molecular fragments of PTH." Cosman et al. (15) , using methylprednisolone in a pharmacologic dose of 1 g intravenously, noted no change after 25 hours in either serum ionized calcium or intact molecule PTH measured by an immunometric assay. Only after 1 week of daily administration of 1 g of methylprednisolone intravenously was a statistically significant (but minimal) increase in PTH (approximately 15%) over baseline noted. The ionized calcium, however, did not change. Similar lack of change in total and corrected serum calcium and intact PTH after daily oral administration of 15 mg of prednisolone was reported by Hattersley et al. (16) . Collectively, these data are consistent with the hypothesis that the subsequent ionized hypocalcemia in our three patients was not a direct result of glucocorticoid administration and more consistent with either the underlying adrenal insufficiency or the effect of volume expansion from intravenous therapy with saline.
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Indeed, Steele (17) demonstrated that a volume expansion of 10% using isotonic saline in 16 normal human subjects resulted in a decrease of plasma ultrafiltrable calcium from 2.50 to 2.33 mEq/L (P<0.001). Total calcium decreased from 4.47 to 3.9 mEq/L (P<0.001), and total magnesium decreased from 1.48 to 1.34 mEq/L (P<0.001). Similar results were demonstrated in dogs by Schneider et al. (18) and Hebert et al. (19) , except that serum phosphorus also declined significantly in both of these studies. Finally, when Schneider et al. (20) infused six dogs with a calcium-free Ringer solution, they demonstrated a decrease of 0.55 mg/dL in serum ionized calcium and a concurrent and significantly correlated increase in serum PTH of 54 µL Eq/mL. Addition of 6 mg/dL of calcium to the Ringer solution prevented the increase in serum PTH. Together with the long-recognized effect of glucocorticoids in decreasing renal phosphate reabsorption (21-23), we are able to hypothesize a partial mechanism for the phenomenon of transient ionized hypocalcemia and secondary hyperparathyroidism in acute adrenal insufficiency and its treatment. After the initial low corrected serum calcium levels (likely due to the adrenal insufficiency or its precipitating cause), volume expansion with isotonic saline led to or exacerbated the ionized hypocalcemia. In turn, this situation resulted in an appropriate increase in PTH and caused a state of secondary hyperparathyroidism. As a result of the combination of increased PTH and hypophosphatemia from the phosphaturic effect of secondary hyperparathyroidism, volume expansion with isotonic saline, or glucocorticoids, the kidney 1α-hydroxylase enzyme was stimulated, and increased levels of 1,25(OH)2D were produced. It may be argued that chronic vitamin D deficiency, as demonstrated by our first patient, had a causal role in the development of ionized hypocalcemia. Although we cannot categorically exclude this possibility, it seems unlikely for at least three reasons. First, previous studies in other acutely ill patients with accompanying ionized hypocalcemia have shown heterogeneity of 25(OH)D levels (1). Second, it was not present in our two patients (cases 2 and 3) who had normal circulating levels of 25(OH)D. Third, persistently low levels of 25(OH)D after the normalization of serum ionized calcium and PTH in one patient (case 1) argues against its being necessary for the development of the hypocalcemia and in favor of the primary role of infusion of saline and glucocorticoid therapy or adrenal insufficiency (or both) as its precipitating cause.
Similarly, one might invoke hypomagnesemia as a factor contributing to hypocalcemia and secondary hyperparathyroidism in case 3. Even though we again cannot categorically exclude this factor, the amount of replacement magnesium needed to restore magnesium values to normal was sufficiently minimal to raise serious questions about its relevance.
CONCLUSION
In this report, we describe three patients with the syndrome of acute, transient ionized hypocalcemia and secondary hyperparathyroidism in association with acute adrenal insufficiency and its therapy. Similar to the syndrome of acute ionized hypocalcemia in other illnesses in which a definitive causative factor has not been identified, that associated with acute adrenal insufficiency and its therapy may have a multifactorial basis (1). Nonetheless, unlike the situation in other acute illnesses, there is reason to hypothesize a causal role for the therapy with both intravenously administered saline and glucocorticoids. Irrespective of the mechanism, however, it is important to recognize this disorder of calcium homeostasis in association with acute adrenal insufficiency in addition to the better-known presence of hypercalcemia.
ADDENDUM
Patient 2 experienced another episode of acute adrenal insufficiency in November 1997. It was characterized by a minimal total serum calcium of 7.2 mg/dL, ionized calcium of 1.08 mmol/L, normal 25(OH)D and magnesium levels, and a maximum 1,25(OH)2D of 89 pg/mL and PTH of 91 pg/mL. All analytes returned to normal with intravenously administered hydrocortisone and isotonic saline therapy.
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